General practitioners have a key role in coordinating the care of patients with incisional hernia, in terms of detection, referral and optimisation of contributory comorbidities.

Despite international consensus regarding the judicious use of diagnostic spinal imaging, patients continue to be over-referred.

Assessment and surveillance for developmental dysplasia of the hip (DDH) in the general practice setting may help to reverse a trend of increasing late-diagnosed DDH cases in Australia.

Botulinum neurotoxin is an effective treatment for various movement disorders that are disabling and frequently under-recognised.

Medications may be used in conjunction with non-pharmacological treatments to manage cognition, function and behaviour in people with Alzheimer’s disease.

The demographic transition in the general practice patient population necessitates that general practitioners take a bigger role in diagnosing dementia.

With the advent of new treatments, the outcomes of myeloma have changed drastically in the past decade.

GPs have an integral role in the journey of patients with this surgically treated condition.

Nocturia is associated with significant morbidity and is likely to be a marker of poor health.

Female pattern hair loss can affect women of all ages with significant morbidity and may be the first sign of an underlying systemic condition.

Benign prostatic hyperplasia, the most common benign tumour in men, is generally initially assessed and managed by a general practitioner in the primary healthcare setting.

Global climate change is a major threat to public health in the 21st century, therefore an understanding of the consequences and the possible responses is vital.

The aim of this article is to provide an overview of the nonavalent HPV vaccine, the rationale for its use, and the updated dose scheduling requirements for HPV vaccine.

Preconception care addresses the biomedical, behavioural and social health of women and their partners prior to pregnancy, and has far-reaching benefits for mothers and children.

Australia has adopted innovative, evidence-based criteria for the inclusion of HPV NAT assays in the renewed NCSP.